Home
Scholarly Works
P131 Patients with severe eosinophilic asthma...
Conference

P131 Patients with severe eosinophilic asthma achieved remission over 2 years with benralizumab: integrated analysis of the >1000-patient, multinational, real-world XALOC-1 study

Authors

Pelaia G; Jackson D; Nair P; Emmanuel B; Tran T; Menzies-Gow A; Watt M; Kayaniyil S; Boarino S; Nuevo J

Pagination

pp. a185.2-a1a186

Publisher

BMJ

Publication Date

November 1, 2023

DOI

10.1136/thorax-2023-btsabstracts.283

Name of conference

‘The way you make me feel’ – Beyond the basics in asthma
View published work (Non-McMaster Users)

Contact the Experts team